Bruns Ingmar

Zentalis Pharmaceuticals, Inc. · Chief Medical Officer

Bruns Ingmar is listed in public filings as officer: Chief Medical Officer. This Bruns Ingmar insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Zentalis Pharmaceuticals, Inc. (ZNTL). Investors use Bruns Ingmar's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

History Trades

CompanyValueActionPriceCurrent Price
Zentalis Pharmaceuticals, Inc.ZNTL$7.2k3k sharesSellFeb 6, 2026$2.43--
Zentalis Pharmaceuticals, Inc.ZNTL$46k20k sharesBuyFeb 6, 2025$2.28--
Bruns Ingmar History Trades | TradingNote